SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-247867
Filing Date
2018-08-14
Accepted
2018-08-14 07:47:55
Documents
46
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d595680d10q.htm 10-Q 244363
2 EX-31.1 d595680dex311.htm EX-31.1 9759
3 EX-31.2 d595680dex312.htm EX-31.2 9746
4 EX-32.1 d595680dex321.htm EX-32.1 5657
5 EX-32.2 d595680dex322.htm EX-32.2 5212
  Complete submission text file 0001193125-18-247867.txt   1951095

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20180630.xml EX-101.INS 227315
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20180630.xsd EX-101.SCH 29314
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20180630_cal.xml EX-101.CAL 29103
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20180630_def.xml EX-101.DEF 178671
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20180630_lab.xml EX-101.LAB 249798
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20180630_pre.xml EX-101.PRE 208364
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 181014304
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1